| Names | |
|---|---|
|
IUPAC name
(1R,2R,3S,6S,7S,9S,10R,11S,12R,13S,14R)-2,6,9,11,13,14-Hexahydroxy-11-isopropyl-3,7,10-trimethyl-15-oxapentacyclo [7.5.1.01,6.07,13.010,14]pentadec-12-yl 1H-pyrrole-2-carboxylate
|
|
| Identifiers | |
|
15662-33-6 |
|
| 3D model (Jmol) | Interactive image |
| ChEBI |
CHEBI:8925 |
| ChEMBL |
ChEMBL612231 |
| ChemSpider |
16736002 |
| ECHA InfoCard | 100.036.105 |
| 4303 | |
| KEGG |
C08705 |
| MeSH | Ryanodine |
| PubChem | 5114 |
|
|
|
|
| Properties | |
| C25H35NO9 | |
| Molar mass | 493.547 g/mol |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
|
|
|
| Infobox references | |
Ryanodine is a poisonous diterpenoide found in the South American plant Ryania speciosa (Salicaceae). It was originally used as an insecticide.
The compound has extremely high affinity to the open-form ryanodine receptor, a group of calcium channels found in skeletal muscle, smooth muscle, and heart muscle cells. It binds with such high affinity to the receptor that it was used as a label for the first purification of that class of ion channels and gave its name to it.
At nanomolar concentrations, ryanodine locks the receptor in a half-open state, whereas it fully closes them at micromolar concentration. The effect of the nanomolar-level binding is that ryanodine causes release of calcium from calcium stores as the sarcoplasmic reticulum in the cytoplasm, leading to massive muscular contractions. The effect of micromolar-level binding is paralysis. This is true for both mammals and insects.